Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Find out Where To Position Dividend Aristocrats Etf In Portfolio to optimize diversification, risk, and income potential within a blended strategy.
18,597 articlesA trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
Radian Group confirms it will wind down its mortgage conduit business following a divestiture review, while continuin...
Longbridge Financial has rolled out RetentionIQ, a program to protect broker-originated loan pipelines from direct re...
Markets show the U.S. dollar rising as Iran tensions mount, while select crypto assets climb, creating an unusual cro...
As AI accelerates, blue-collar automation could reshape factory floors. This piece examines which robotics stocks sta...
Top-tier buyers are steering a different cycle as higher rates soften the broader market. Wealth migration and long-t...
A sharp 20% plunge in Circle tokens sparked by yield shifts under a new Clarity Act framework. This morning minute re...
Retirement planning isn’t a one-size-fits-all plan. As you age, your priorities, risks, and income needs shift. This ...
Unlock the value hidden in the 2026 earnings call transcript. This guide shows you how to parse management commentary...
A new wave of fiber-infused sodas and gummies is hitting shelves as 'fibermaxxing' spurred a fiber push across snacks...
JPMorgan expands its institutional cash toolbox by assigning Ethereum and Solana to separate roles in a new on-chain ...
Douglas Elliman expands into New Hampshire, recruiting Adam Pettitt to The Sarkis Team and debuting LOOKOUT Lake Winn...